Description
- Rapid Covid-19 Antigen Test
- Accurate, reliable, and fast
- Store and use at room temperature
- Complete kit, easy to use [25-pack]
- Certifications: CE, ISO 13485: 2016
The VivaDiag SARS-CoV-2 Ag Rapid Test is based on immunoassay technology for the rapid and qualitative detection of the SARS-CoV-2 nucleocapsid protein antigen in humans oropharyngeal or nasopharyngeal swab specimens. The test generates a result in 15 minutes that identify people infected with COVID-19 and quickly helps contain the spread of the virus.
The kit contains all the necessary items, including the swab, the extraction tube, the extraction solution, and the lateral flow test device. No specialized equipment or personnel are required to use this test. The tests can be performed anywhere and at any time by trained personnel, that is, for professional use only. This Rapid Lateral Flow Covid-19 Antigen Test Kit is simple for trained personnel to administer and provides accurate results quickly using the oropharyngeal or nasopharyngeal swab specimen.
With the sample collected, insert the swab into the extraction tube filled with extraction solution. After taking a test device out of the sealed bag, apply 3 drops of the solution and wait 15 minutes before reading the test, a positive or negative result is clearly indicated. This rapid Covid-19 antigen test kit has an overall accuracy of 98.79%, a specificity of 99.12%, and a sensitivity of 90.90%, providing a total guarantee of fast, accurate, and reliable results.
These tests should be used as part of a fully integrated COVID-19 strategy, helping to identify those infected to reduce the spread of the virus. The VivaDiag ™ SARS-CoV-2 Ag Rapid Test is designed ONLY to act as an adjunct test for suspected cases of negative nucleic acid detection by coronavirus or in conjunction with nucleic acid detection in the diagnosis of suspected cases. Nucleocapsid protein antigen test results should not be used as the sole basis for diagnosing or excluding SARS-CoV-2 (COVID-19) infection or for reporting infection status.